Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Escobar

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
EMBO Molecular Medicine|January 16, 2016
IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironmentMario Catarinella, Andrea Monestiroli, Giulia Escobar, et al.
Cell Reports. Medicine|July 3, 2024
Pan-cancer mapping of single CD8<sup>+</sup> T cell profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunityKatherine Tooley, Livnat Jerby, Giulia Escobar, et al.
EMBO Molecular Medicine|August 30, 2021
Myeloid cell-based delivery of IFN-γ reprograms the leukemia microenvironment and induces anti-tumoral immune responsesAdele Mucci, Gabriele Antonarelli, Carolina Caserta, et al.
Cancer Cell|August 13, 2015
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer TherapyRoberto Ronca, Arianna Giacomini, Emanuela Di Salle, et al.
Nature Communications|December 10, 2025
Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancerSangwoo Park, Cassidy E Ho, Eli P Darnell, et al.
Nature|May 30, 2014
Targeted genome editing in human repopulating haematopoietic stem cellsPietro Genovese, Giulia Schiroli, Giulia Escobar, et al.
Cancer Cell|August 25, 2023
Tumor immunogenicity dictates reliance on TCF1 in CD8<sup>+</sup> T cells for response to immunotherapyGiulia Escobar, Katherine Tooley, Joan Pagès Oliveras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2025
Ibrutinib and PD-1 blockade potentiate mesothelin-targeting CAR-T cell therapy in preclinical models of pancreatic cancerAlexander Armstrong, Graziella van der Plancke, Sae Nishiguchi, et al.
Nature Communications|November 2, 2025
On-target off-tumor toxicity of claudin18.2-directed CAR-T cells in preclinical modelsFilippo Birocchi, Antonio J Almazan, Aiyana Parker, et al.
Immunity|October 24, 2024
Transcription factor TCF1 binds to RORγt and orchestrates a regulatory network that determines homeostatic Th17 cell stateDavide Mangani, Ayshwarya Subramanian, Linglin Huang, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
EMBO Molecular Medicine|January 16, 2016
IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironmentMario Catarinella, Andrea Monestiroli, Giulia Escobar, et al.
Cell Reports. Medicine|July 3, 2024
Pan-cancer mapping of single CD8<sup>+</sup> T cell profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunityKatherine Tooley, Livnat Jerby, Giulia Escobar, et al.
EMBO Molecular Medicine|August 30, 2021
Myeloid cell-based delivery of IFN-γ reprograms the leukemia microenvironment and induces anti-tumoral immune responsesAdele Mucci, Gabriele Antonarelli, Carolina Caserta, et al.
Cancer Cell|August 13, 2015
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer TherapyRoberto Ronca, Arianna Giacomini, Emanuela Di Salle, et al.
Nature Communications|December 10, 2025
Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancerSangwoo Park, Cassidy E Ho, Eli P Darnell, et al.
Nature|May 30, 2014
Targeted genome editing in human repopulating haematopoietic stem cellsPietro Genovese, Giulia Schiroli, Giulia Escobar, et al.
Cancer Cell|August 25, 2023
Tumor immunogenicity dictates reliance on TCF1 in CD8<sup>+</sup> T cells for response to immunotherapyGiulia Escobar, Katherine Tooley, Joan Pagès Oliveras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2025
Ibrutinib and PD-1 blockade potentiate mesothelin-targeting CAR-T cell therapy in preclinical models of pancreatic cancerAlexander Armstrong, Graziella van der Plancke, Sae Nishiguchi, et al.
Nature Communications|November 2, 2025
On-target off-tumor toxicity of claudin18.2-directed CAR-T cells in preclinical modelsFilippo Birocchi, Antonio J Almazan, Aiyana Parker, et al.
Immunity|October 24, 2024
Transcription factor TCF1 binds to RORγt and orchestrates a regulatory network that determines homeostatic Th17 cell stateDavide Mangani, Ayshwarya Subramanian, Linglin Huang, et al.
Pageof 3